MycoDAO
- Company typePrivate
- Founded2025
- HeadquartersChula Vista, United States
- Headcount1–10
- GTM typeB2C
- OfferingServices
What MycoDAO does
MycoDAO is a mycology-focused decentralized autonomous organization (BioDAO) that connects researchers, citizen scientists, laboratories, funders, and biotech builders through token-based community governance. The organization is structured as a non-profit DAO using the MYCO governance token and the Realms governance platform to allocate decentralized funding and make collective decisions about research priorities, rather than operating through traditional equity or institutional hierarchies.
The product ecosystem consists of five integrated components: LAB-IN-A-BOX modular laboratory facilities providing DNA sequencing, tissue storage, microscopy, biobanking, and automated research equipment; FungIP, a platform for managing and tokenizing fungal intellectual property; BLOCKS, a content and market intelligence platform covering bio funding and mycology research; the MYCO governance token distributed via the bio.xyz launchpad; and the underlying DAO governance framework itself. Underlying technology combines hardware (field sensors, lab equipment, environmental monitoring), software, AI tools and autonomous agents, bioinformatics, and data platforms into a decentralized scientific infrastructure designed to span the full pipeline from field discovery to commercial biotech application.
The business model is multi-stream and still early-stage. Described revenue streams include tokenized IP and licensing (FungIP), decentralized funding and grants managed through DAO governance, fee-for-service laboratory capabilities (DNA sequencing, microscopy, tissue storage), and recurring biobanking subscriptions. GTM is community-led, relying primarily on Discord engagement, open governance proposals, and content marketing rather than direct sales. Target customer segments span four primary personas: individual researchers and citizen scientists, science funders and investors, laboratories and research institutions, and biotech entrepreneurs building applications in medicine, agriculture, materials, fungal computing, and ecological restoration.
MycoDAO firmographics
Firmographics- Name
- MycoDAO
- Website
- https://MycoDAO.com
- Company type
- Private
- Founded year
- 2025
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Ownership category
- akta.pro rank
MycoDAO industry classification
Industry- Product category
- Decentralized Science Infrastructure
- NAICS
- Medical and Diagnostic Laboratories (6215), Business Associations (813910), Blood and Organ Banks (621991)
- SIC
- Services-Commercial Physical & Biological Research (8731), Services-Membership Organizations (8600)
- akta.pro primary industry
- Synthetic Biology & Genetic Circuit Design Platforms (pathway engineering, chassis development) (HLAAAIAD)
- akta.pro secondary industries
- Mycoprotein & Fungal Proteins (Fusarium/Mycelium-Based) (AFAJAHAE), Sample Logistics, Biorepository & IVD Kit Management (Trial Support) (HLAGAEAI)
Keywords
Where MycoDAO is headquartered
LocationHeadquarters
- HQ city
- Chula Vista
- HQ country
- United States
- HQ region
- North America
Markets served
MycoDAO business model
Business model- GTM type
- B2C
- Offering type
- Services
- Cost components
- Operations, Technology or R&D, Infrastructure, Personnel
Revenue model
- Tokenized IP and Licensing: Monetizing fungal intellectual property through tokenization, creating licensing models that generate revenue from discoveries while enabling community ownership.
- Decentralized Funding and Grants: Community-governed funding mechanisms that allocate capital to research projects, with grant distribution managed through DAO governance.
- Laboratory Services: Fee-for-service laboratory capabilities including DNA sequencing, microscopy, tissue storage, and biobanking services for external researchers and partners.
- Biobanking Services: Specimen preservation and storage services for the scientific community, generating recurring revenue from maintained collections.
Go-to-market motion1 record
Distribution channels3 records
Marketing channels4 records
MycoDAO product offering
Product offeringCore offering
MycoDAO is a decentralized autonomous organization (BioDAO) focused on mycology that operates physical laboratory infrastructure (LAB-IN-A-BOX facilities), provides DNA sequencing, tissue storage, microscopy, and biobanking services, and channels community-governed decentralized funding and tokenized IP licensing toward fungal research and biotechnology development. It connects researchers, citizen scientists, labs, funders, and builders through software platforms including BLOCKS, FungIP, and the MYCO governance token.
Product overview
MycoDAO is a decentralized science platform organized as a BioDAO that bridges nature, funding, and scientific discovery in mycology. The ecosystem consists of MycoDAO as the core governance platform, the MYCO Token for community governance, BLOCKS as a market news and bio funding platform, FungIP for intellectual property management, and LAB-IN-A-BOX facilities providing physical laboratory infrastructure for DNA sequencing, tissue storage, microscopy, and biobanking. Together, these products create a pipeline connecting field discovery, lab infrastructure, AI tools, biological data, community funding, and commercialization.
Differentiator
Problem solved
Functional benefit
Brands
- FungIP: Intellectual property initiative focused on fungal discoveries and licensing models
Products and services
- MycoDAO Platform
Companies that use MycoDAO
Customer profileSegments4 records
Ideal customer profiles4 records
MycoDAO technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature7 records
MycoDAO partnerships and signals
Strategic signalRecent moves6 records
Expansion highlights5 records
MycoDAO competitors and assessment
Company assessmentBroad incumbents
- Perfect Day:
- Ginkgo Bioworks: Ginkgo Bioworks is a publicly traded synthetic biology platform that programs cells for industrial applications. Comparable to MycoDAO's AI/bioinformatics and synthetic biology positioning, but operates at vastly larger scale and scope with a centralized business model.
Direct peers
- Molecule: Molecule is a DeSci platform that tokenizes and funds biotech intellectual property through DAOs. It shares MycoDAO's exact model of using Web3 primitives to fund, govern, and license scientific IP — the closest analog in the DeSci ecosystem.
- VitaDAO: VitaDAO is a longevity-focused BioDAO that funds research through community-governed token treasuries and tokenizes resulting IP. Comparable to MycoDAO in structure (DAO governance, IP tokenization, lab infrastructure partnerships) but applied to longevity research.
- LabDAO: LabDAO is a decentralized autonomous lab network connecting researchers with shared wet-lab infrastructure and tools. Directly comparable to MycoDAO's LAB-IN-A-BOX and biobanking offering; both target underfunded researchers with decentralized infrastructure.
- AthenaDAO: AthenaDAO is a BioDAO funding women's health research through token-governed grants and IP tokenization. Comparable operating model and governance structure to MycoDAO, though focused on a different scientific vertical.
- MycoTechnology: MycoTechnology is a fungal fermentation company producing food ingredients from mycelium. Directly comparable to MycoDAO's biotech-builder vertical — particularly alternative protein and food applications — though it operates as a centralized CPG ingredient supplier.
- Ecovative Design: Ecovative grows mycelium-based packaging, materials, and leather substitutes. Comparable on the materials and bioremediation verticals MycoDAO targets; operates as a centralized commercial supplier rather than a DAO.
Others
- Bio.xyz: Bio.xyz is the DeSci launchpad through which MycoDAO distributes its MYCO token. It is an ecosystem infrastructure provider — enabling BioDAO creation — rather than a direct competitor, but serves as the closest platform-level peer.
Emerging players
- Meati Foods: Meati Foods produces whole-cut protein from mycelium. Comparable to MycoDAO's biotech-builder segment in alternative protein; operates a single-vertical commercial model rather than the multi-vertical DAO approach.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat4 records
Key risks5 records
Key highlights5 records
Customer concentration
MycoDAO social profiles
Digital presenceMycoDAO financial estimates
Financial estimateRevenue estimate
Valuation estimate
MycoDAO leadership team
Management profileNumber of profiles
MycoDAO funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
MycoDAO M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about MycoDAO
What does MycoDAO do?
MycoDAO is a decentralized autonomous organization (BioDAO) focused on mycology that operates physical laboratory infrastructure (LAB-IN-A-BOX facilities), provides DNA sequencing, tissue storage, microscopy, and biobanking services, and channels community-governed decentralized funding and tokenized IP licensing toward fungal research and biotechnology development. It connects researchers, citizen scientists, labs, funders, and builders through software platforms including BLOCKS, FungIP, and the MYCO governance token.
Is MycoDAO a public or private company?
MycoDAO is a private company. It is classified as nonprofit foundation owned and is currently operating.
When was MycoDAO founded?
MycoDAO was founded in 2025. It employs 1 to 10 people.
Where is MycoDAO based?
MycoDAO is headquartered in Chula Vista, United States, in the North America region.
How does MycoDAO make money?
Four revenue lines are on record. Tokenized IP and Licensing is the primary driver. The others are decentralized Funding and Grants, laboratory Services and biobanking Services.
Who are MycoDAO's main competitors?
Broad incumbents on record are Perfect Day and Ginkgo Bioworks. Direct peers are Molecule, VitaDAO, LabDAO, AthenaDAO, MycoTechnology and Ecovative Design. Bio.xyz is listed as an others. Meati Foods is listed as an emerging player.
Does MycoDAO have an API?
No public API is recorded for MycoDAO.
What industry is MycoDAO in?
MycoDAO's product category is Decentralized Science Infrastructure. Its primary akta.pro industry code is HLAAAIAD, Synthetic Biology & Genetic Circuit Design Platforms (pathway engineering, chassis development), with a secondary code of AFAJAHAE, Mycoprotein & Fungal Proteins (Fusarium/Mycelium-Based). Its NAICS code is 6215 and its SIC code is 8731.